Biocatalysed synthesis of β-O-glucosides from 9-fluorenon-2- carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties

Bioorganic and Medicinal Chemistry

Volumn 13, Issue 10, 2005, Pages 3371-3378

  Alcaro, Stefano ^a   Arena, Adriana ^b   Di Bella, Rosaria ^b   Neri, Simonetta ^b   Ottanà, Rosaria ^b   Ortuso, Francesco ^a   Pavone, Bernadette ^b   Trincone, Antonio ^c   Vigorita, Maria Gabriella ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c CNR   (Italy)

Author keywords

9 Fluoren b O glycosides; 9 Fluorenon 2 carbohydroxyesters; Conformational analysis; Enzymatic transglycosylation; IFN inducing properties; Tilorone analogues

Indexed keywords

2 HYDROXY 2 METHYLETHYL 9 OXO 9H 2 FLUORENECARBOXYLATE; 2 HYDROXYETHYL 9 OXO 9H 2 FLUORENECARBOXYLATE; 3 HYDROXYPROPYL 9 OXO 9H 2 FLUORENECARBOXYLATE; 3 OXA 5 HYDROXYL 1 PENTHYL 9 OXO 9H 2 FLUORENECARBOXYLATE; 4 HYDROXY 1 BUTYL 9 OXO 9H 2 FLUORENECARBOXYLATE; ALPHA INTERFERON; BETA 9 FLUORENEMETHYLGLUCOSIDE; BETA INTERFERON; ENZYME; ESTER DERIVATIVE; FLUORENONE DERIVATIVE; GLUCOSIDE; GLYCOSIDASE; INTERFERON; O BETA [2 (9 OXO 9H 2 FLUORENECARBONYLOXY) 1 ETHYL]GLUCOSIDE; O BETA [2 METHYL 2 (9 OXO 9H 2 FLUORENECARBONYLOXY) 1 ETHYL]GLUCOSIDE; O BETA [3 (9 OXO 9H 2 FLUORENECARBONYLOXY) 1 PROPYL]GLUCOSIDE; O BETA [3 OXA 5 (9 OXO 9H 2 FLUORENECARBONYLOXY) 1 PENTYL]GLUCOSIDE; O BETA [4 (9 OXO 9H 2 FLUORENECARBONYLOXY) 1 BUTYL]GLUCOSIDE; SUGAR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CELL SECRETION; CELL STRAIN U937; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; GLYCOSYLATION; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; MOLECULAR MODEL; REACTION ANALYSIS; STIMULATION; STRUCTURE ANALYSIS; SULFOLOBUS SOLFATARICUS; VIRUS INFECTION; VIRUS REPLICATION;

ARCHAEA; HUMAN HERPESVIRUS 2; SULFOLOBUS SOLFATARICUS;

EID: 17444377503     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.03.016     Document Type: Article

References (39)

1. F.G. Hayden Goodman & Gilman-Le basi farmacologiche della terapia IX ed. 1997 McGraw-Hill Libri Italia srl Milano Chapter 50, pp 1161-1193
2. B.A. Chabner, C.J. Allegra, G.A. Curt, and P. Calabresi Goodman & Gilman-Le basi farmacologiche della terapia IX ed. 1997 McGraw-Hill Libri Italia srl Milano Chapter 51, pp 1203-1254
3. M. Saijo, Y. Yasuda, H. Yabe, S. Kato, T. Suzutani, E. De Clercq, M. Niikura, A. Maeda, I. Kurane, and S. Morikawa J. Med. Virol. 68 2002 99
4. F. Nugier, J.N. Colin, M. Aymard, and M. Langlois J. Med. Virol. 36 1992 1
5. C. Danve-Szatanek, M. Aymard, D. Thouvenot, F. Morfin, G. Agius, I. Bertin, S. Billaudel, B. Chanzy, M. Coste-Burel, L. Finkielsztejn, H. Fleury, T. Hadou, C. Henquell, H. Lafeuille, M.E. Lafon, A. Le Faou, M.C. Legrand, L. Maille, C. Mengelle, P. Morand, F. Morinet, E. Nicand, S. Omar, B. Picard, B. Pozzetto, J. Puel, D. Raoult, C. Scieux, M. Segondy, J.M. Seigneurin, R. Teyssou, and C. Zandootti J. Clin. Microbiol. 42 2004 242
6. B. Sainz, and W.P. Halford J. Virol. 76 2002 11541
7. S. Goodbourn, L. Didcock, and R.E. Randall J. Gen. Virol. 81 2000 2341
8. T. Taniguchi, and A. Takaoka Curr. Opin. Immunol. 14 2002 111
9. K. Hirota, K. Kazaoka, I. Niimoto, H. Kumihara, H. Sajiki, Y. Isobe, H. Takaku, M. Tobe, H. Ogita, T. Ogino, S. Ichii, A. Kurimoto, and H. Kawakami J. Med. Chem. 45 2002 5419
10. E.R. Andrews, R.W. Fleming, J.M. Grisar, J.C. Kihm, D.L. Wenstrup, and G.D. Mayer J. Med. Chem. 17 1974 882
11. W.L. Albrecht, R.W. Fleming, S.W. Horgan, J.C. Kihm, and G.D. Mayer J. Med. Chem. 17 1974 886
12. R.L. Soehner, M.M. Gambardella, E.F. Hou, and M. Pollard Proc. Soc. Exp. Biol. Med. 145 1974 1114
13. P. Chandra, and G. Wright Top. Curr. Chem. 72 1977 125
14. R.F. Krueger, and G.D. Mayer Science 169 1970 1213
15. J. Fischer Biochem. J. 312 1995 215
16. F. Arcamone Doxorubicin-Anticancer Antibiotics 1981 Academic New York
17. B. Pullman Advances in Drug Research Vol. 18 1989 Academic New York pp 74-76
18. T. Nogrady Medicinal Chemistry-A Biomedical Approach 2nd ed. 1988 Oxford University Press Chapter 6, pp 408-412
19. J. Fisher, H. Lullmann, and R. Lullmann-Rauch Gen. Pharmacol. 27 1996 1317
20. R. Lullmann-Rauch Exp. Toxicol. Pathol. 46 1994 315
21. M. Prokopek Biochem. Pharmacol. 42 1991 2187
22. D.J. Fenick J. Med. Chem. 40 1997 2452
23. J.F. Fisher, A.W. Harrison, G.L. Bundy, K.F. Wilkinson, B.D. Rush, and M.J. Ruwart J. Med. Chem. 34 1991 4140
24. S. Alcaro, A. Arena, S. Neri, R. Ottanà, F. Ortuso, B. Pavone, and M.G. Vigorita Bioorg. Med. Chem. 12 2004 1781
25. S. Alcaro, A. Arena, R. Di Bella, S. Neri, R. Ottaná, F. Ortuso, B. Pavone, and M.G. Vigorita Arkivoc 5 2004 334
26. A. Trincone, B. Nicolaus, L. Lama, P. Morzillo, M. De Rosa, and A. Gambacorta Biotechnol. Lett. 13 1991 235
27. A. Trincone, R. Improta, R. Nucci, M. Rossi, and A. Gambacorta Biocatalysis 10 1994 195
28. M. Santin, F. Rosso, A. Sada, G. Peluso, R. Improta, and A. Trincone Biotechnol. Bioeng. 49 1996 217
29. 12O, MW 196.25; mp 105-107°C, Aldrich
30. W.C. Still, A. Tempczyk, R.C. Hawley, and T. Hendrickson J. Am. Chem. Soc. 112 1990 6127
31. F. Mohamadi, N.G.J. Richards, W.C. Guida, R. Liskamp, M. Lipton, C. Caufield, G. Chang, T. Hendrickson, and W.C. Still J. Comput. Chem. 11 1990 440
32. P. Harle, V. Cull, L. Guo, J. Papin, C. Lawson, and D.J. Carr Antiviral Res. 2002 39 49
33. F. Oberman, and A. Panet J. Interferon Res. 1989 563 571
34. R.L. Hendricks, P.C. Weber, J.L. Taylor, A. Koumbis, T.M. Tumpey, and J.C. Glorioso J. Gen. Virol. 1991 1601 1610
35. K.L. Mossman, H.A. Saffran, and J.R. Smiley J. Virol. 2000 2052 2056
36. J.A. Murphy, R.J. Duerst, T.J. Smith, and L.A. Morrison J. Virol. 2003 9337 9345
37. J.L. Taylor, S.D. Little, and W.J. O'Brien J. Interferon Cytokine Res. 1998 159 165
38. L. Bonina, A. Arena, B.G. Costa, D. Altavilla, and P. Mastroeni J. Immunol. Res. 3 1991 24 30
39. M. Taimi, H. Defacque, T. Commes, J. Favero, E. Caron, J. Marti, and J. Dornand Immunology 79 1993 229